Paladin Labs has entered into a licensing and distribution agreement with Dynamiclear Australia, under which Paladin receives the exclusive rights to market and sell cold sore treatment Dynamiclear Rapid in Canada. Paladin also received an option to acquire rights to Dynamiclear’s antiviral formulation for Herpes Simplex Virus-2 infections, which is currently under development. Financial terms were not disclosed.   “We are pleased to add Dynamiclear Rapid to our OTC portfolio. Cold sores are one...